Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000265460 is a novel pseudogene with sequence similarity to the functional gene transcription factor CP2-like 1 (TFCP2L1). Pseudogenes are segments of DNA that have high homology to known genes but lack the ability to encode functional proteins due to deleterious mutations such as premature stop codons or frameshifts[2][4]. This specific pseudogene does not participate in known biological processes or disease pathways, nor is it considered a receptor, enzyme, transporter, or transcription factor in a manner relevant to therapeutic targeting. Its annotation as “similar to TFCP2L1” indicates it may share sequence features but does not contribute to TFCP2L1-regulated activities such as embryonic stem cell pluripotency[1][3]. As a result, it is not considered a valid drug target, biomarker, or source of safety concern in pharmaceutical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel pseudogene similar to transcription factor CP2-like 1.